<DOC>
	<DOCNO>NCT02828345</DOCNO>
	<brief_summary>This research trial study level type biomarker , circulate tumor cell ( CTCs ) , blood patient stage I-IV melanoma . A biomarker biological molecule find blood , body fluid , tissue sign normal abnormal process , condition disease . A biomarker may use see well body responds treatment disease condition . Studying sample blood laboratory obtain treatment patient melanoma may help doctor learn change occur CTC level whether may predict well patient respond therapy .</brief_summary>
	<brief_title>Bio-marker Analysis Using Circulating Tumor Cells Patients With Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Subjects must sign tissue collection consent describe protocol IRB # 703001 , UPCC # 08607 , PI : Giorgos Karakousis , MD Subjects must competent consent . Subjectsmust adult ( 18 year old ) . Subjects must initiate new therapy melanoma ( pretreatment CTC count obtain ) . Children ( less 18yrs ) Patients pretreatment CTC level obtain .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>